It is important to understand the regulation of the Amyloid Precursor Protein (APP) gene expression because epidemiologic studies show that Alzheimer Disease (AD) is exquisitely sensitive to gene dosage [1], and levels of APP expression including β-peptide levels correlate with the severity and age-of-onset of AD [2]. Here, APP is linked to Alzheimer disease.